Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.350
-0.160 (-10.60%)
May 15, 2026, 4:00 PM EDT - Market closed

Allarity Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
21179318778
Market Cap Growth
4.47%103.27%163.38%-98.26%138.20%-
Enterprise Value
22.562.68-10.994.82192.5360.78
Last Close Price
1.351.081.17330.66246792.008714580.00
PE Ratio
--1.38-0.07-0.05-0.01-2.48
PS Ratio
60.5054.27----
PB Ratio
3.091.770.72-0.72-1653.294.32
P/TBV Ratio
3.031.580.16-0.25-1237.60145.38
P/FCF Ratio
--1.17-0.48-0.25-11.10-5.27
P/OCF Ratio
--1.17-0.49-0.25-11.11-5.27
EV/Sales Ratio
65.388.38----
EV/EBITDA Ratio
--0.210.40-0.28-5.60-2.30
EV/EBIT Ratio
--0.210.40-0.28-5.59-2.29
EV/FCF Ratio
--0.180.62-0.38-11.44-4.08
Debt / Equity Ratio
2.900000.960.05
Debt / EBITDA Ratio
-1.70-0.11-0.05-0.08-0.11-0.04
Debt / FCF Ratio
-1.29-0.09-0.08-0.10-0.22-0.07
Net Debt / Equity Ratio
0.24-1.35-1.54-0.25-15.10-1.04
Net Debt / EBITDA Ratio
-0.131.050.67-0.07-0.050.71
Net Debt / FCF Ratio
-0.100.901.03-0.09-0.101.26
Asset Turnover
0.000.020000
Quick Ratio
0.751.842.000.070.251.00
Current Ratio
1.232.132.060.140.441.03
Return on Equity (ROE)
-134.33%-103.80%-541.17%-2084.24%-137.78%-121.53%
Return on Assets (ROA)
-47.30%-61.63%-160.28%-128.82%-98.11%-63.64%
Return on Invested Capital (ROIC)
-488.90%256.46%1240.54%-545.94%-254.92%-108.68%
Return on Capital Employed (ROCE)
-150.19%-116.50%-573.13%-3368.53%-213.82%-93.53%
Earnings Yield
-53.90%-72.22%-1337.61%-1824.02%-15041.60%-40.39%
FCF Yield
-80.01%-85.38%-206.57%-392.87%-9.01%-18.98%
Buyback Yield / Dilution
-254.81%-794.77%-47373.86%-497.35%-87.14%-7691.05%
Total Shareholder Return
-254.81%-794.77%-47373.86%-497.35%-87.14%-7691.05%
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q